These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8026297)

  • 1. Effects of cholecystokinin antagonists on the discriminative stimulus effects of cocaine in rats and monkeys.
    Massey BW; Vanover KE; Woolverton WL
    Drug Alcohol Depend; 1994 Jan; 34(2):105-11. PubMed ID: 8026297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of cholecystokinin antagonists to modify the discriminative stimulus effects of cocaine.
    Spealman RD
    Pharmacol Biochem Behav; 1992 Oct; 43(2):613-6. PubMed ID: 1438498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CCKA receptor antagonist devazepide does not modify opioid self-administration or drug discrimination: comparison with the dopamine antagonist haloperidol.
    Higgins GA; Joharchi N; Wang Y; Corrigall WA; Sellers EM
    Brain Res; 1994 Mar; 640(1-2):246-54. PubMed ID: 8004452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Several roles of CCKA and CCKB receptor subtypes in CCK-8-induced and LiCl-induced taste aversion conditioning.
    Mosher JT; Johnson MF; Birkemo LS; Ervin GN
    Peptides; 1996; 17(3):483-8. PubMed ID: 8735976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area.
    Meltzer LT; Christoffersen CL; Serpa KA; Razmpour A
    Synapse; 1993 Feb; 13(2):117-22. PubMed ID: 8446920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway.
    Crawley JN
    J Neurosci; 1992 Sep; 12(9):3380-91. PubMed ID: 1527584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the reinforcing and discriminative stimulus effects of cocaine in combination with (+)-AJ76 or clozapine.
    Vanover KE; Piercey MF; Woolverton WL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):780-9. PubMed ID: 8355207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCK modulates inhibitory synaptic transmission in the solitary complex through CCKB sites.
    Branchereau P; Champagnat J; Roques BP; Denavit-Saubie M
    Neuroreport; 1992 Oct; 3(10):909-12. PubMed ID: 1330059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation into the discriminative stimulus and reinforcing properties of the CCKB-receptor antagonist, L-365,260 in rats.
    Jackson A; Tattersall D; Bentley G; Rycroft W; Bourson A; Hargreaves R; Tricklebank M; Iversen S
    Neuropeptides; 1994 May; 26(5):343-53. PubMed ID: 8065550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Devazepide, a CCKA receptor antagonist, impairs the acquisition of conditioned reward and conditioned activity.
    Josselyn SA; Franco VP; Vaccarino FJ
    Psychopharmacology (Berl); 1996 Jan; 123(2):131-43. PubMed ID: 8741936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ; Tang KW; Woodruff GN; McKnight AT
    Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCH 23390-induced hypophagia is blocked by the selective CCK-A receptor antagonist devazepide, but not by the CCK-B/gastrin receptor antagonist L-365,260.
    Cooper SJ; Barber DJ
    Brain Res Bull; 1990 Apr; 24(4):631-3. PubMed ID: 2141538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. His381 of the rat CCKB receptor is essential for CCKB versus CCKA receptor antagonist selectivity.
    Jagerschmidt A; Guillaume-Rousselet N; Vikland ML; Goudreau N; Maigret B; Roques BP
    Eur J Pharmacol; 1996 Jan; 296(1):97-106. PubMed ID: 8720482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of cocaine's discriminative stimulus effects by dopamine D(1) agonists in rhesus monkeys.
    Sinnott RS; Nader MA
    Pharmacol Biochem Behav; 2001 Feb; 68(2):301-9. PubMed ID: 11267635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor mediation of the stimulus properties of cholecystokinin.
    Melton PM; Riley AL
    Pharmacol Biochem Behav; 1994 May; 48(1):275-9. PubMed ID: 8029299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of cocaine conditioned place preference induced by stress is reversed by cholecystokinin-B receptors antagonist in rats.
    Lu L; Zhang B; Liu Z; Zhang Z
    Brain Res; 2002 Nov; 954(1):132-40. PubMed ID: 12393241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys.
    Kleven MS; Anthony EW; Woolverton WL
    J Pharmacol Exp Ther; 1990 Jul; 254(1):312-7. PubMed ID: 2195158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual differences in the feeding response to CCKB antagonists: role of the nucleus accumbens.
    Sills TL; Vaccarino FJ
    Peptides; 1996; 17(4):593-9. PubMed ID: 8804067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin A receptor antagonist inhibits feed memory in Japanese quail.
    Berthelot V; Belzung C; Meunier-Salaun MC; Nowak R; Picard M
    Physiol Behav; 1996 Aug; 60(2):575-9. PubMed ID: 8840921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the putative dopamine D3 receptor agonist 7-OH-DPAT in rhesus monkeys trained to discriminate cocaine from saline.
    Lamas X; Negus SS; Nader MA; Mello NK
    Psychopharmacology (Berl); 1996 Apr; 124(4):306-14. PubMed ID: 8739545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.